We are live on ! Find out more
BSX icon

Boston Scientific

853 hedge funds and large institutions have $58B invested in Boston Scientific in 2019 Q4 according to their latest regulatory filings, with 154 funds opening new positions, 301 increasing their positions, 275 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more first-time investments, than exits

New positions opened: 154 | Existing positions closed: 59

123% more funds holding in top 10

Funds holding in top 10: 1329 (+16)

11% more capital invested

Capital invested by funds: $52.3B → $58B (+$5.73B)

11% more funds holding

Funds holding: 770853 (+83)

9% more repeat investments, than reductions

Existing positions increased: 301 | Existing positions reduced: 275

6% more call options, than puts

Call options by funds: $188M | Put options by funds: $176M

0.2% less ownership

Funds ownership: 92.19%91.99% (-0.2%)

Holders
853
Holders Change
+83
Holders Change %
+10.78%
% of All Funds
16.81%
Holding in Top 10
29
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+123.08%
% of All Funds
0.57%
New
154
Increased
301
Reduced
275
Closed
59
Calls
$188M
Puts
$176M
Net Calls
+$11.4M
Net Calls Change
-$82.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Newport Trust Company
26
Newport Trust Company
District of Columbia
$420M -$16.2M -386,692 -4%
American Century Companies
27
American Century Companies
Missouri
$412M +$24.7M +591,070 +7%
Legal & General Group
28
Legal & General Group
United Kingdom
$397M +$9.48M +226,587 +3%
Marshall Wace
29
Marshall Wace
United Kingdom
$370M -$12.2M -292,339 -3%
FAM
30
Fred Alger Management
New York
$359M -$90.1M -2,153,158 -21%
Aberdeen Group
31
Aberdeen Group
United Kingdom
$356M +$7.03M +168,087 +2%
Morgan Stanley
32
Morgan Stanley
New York
$338M +$30.4M +727,425 +11%
MWNA
33
Marshall Wace North America
New York
$334M -$52.9M -1,263,791 -15%
Allianz Asset Management
34
Allianz Asset Management
Germany
$318M -$25.5M -610,369 -8%
VOYA Investment Management
35
VOYA Investment Management
Georgia
$316M -$3.39M -81,053 -1%
AllianceBernstein
36
AllianceBernstein
Tennessee
$307M -$10.8M -257,632 -4%
Charles Schwab
37
Charles Schwab
California
$269M +$4.91M +117,260 +2%
Citadel Advisors
38
Citadel Advisors
Florida
$264M +$8.12M +194,161 +3%
Neuberger Berman Group
39
Neuberger Berman Group
New York
$257M -$3.08M -73,532 -1%
VAM
40
Vontobel Asset Management
New York
$252M -$678K -16,194 -0.3%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$240M +$1.99M +47,607 +0.9%
TP
42
Third Point
New York
$226M
Winslow Capital Management
43
Winslow Capital Management
Minnesota
$215M +$199M +4,757,016 New
O
44
OrbiMed
New York
$211M -$24.9M -593,900 -11%
Swiss National Bank
45
Swiss National Bank
Switzerland
$207M -$18.9M -452,700 -9%
Capital Research Global Investors
46
Capital Research Global Investors
California
$202M +$300K +7,170 +0.2%
UBS AM
47
UBS AM
Illinois
$201M +$2.32M +55,369 +1%
Fidelity International
48
Fidelity International
Bermuda
$195M +$17.2M +410,845 +11%
Millennium Management
49
Millennium Management
New York
$192M +$62.7M +1,499,587 +54%
A
50
AustralianSuper
Australia
$192M -$44M -1,051,384 -20%

BSX Hedge Fund Activity: Q4 2019 in Review

853 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2019, worth a combined $58B — up 11% from $52.3B a quarter earlier.

Buyers outnumbered sellers: 154 funds opened new BSX positions and 59 closed out — a net gain of 95 holders — while 301 added to existing stakes and 275 trimmed.

The largest buyer was Jennison Associates, adding an estimated $399M. The largest seller was Wellington Management Group, cutting an estimated $723M.

  • 853 institutional investors held Boston Scientific (BSX) as of Q4 2019, up from 770 in Q3 2019.
  • Funds reported $58B of Boston Scientific stock for Q4 2019, up 11% quarter-over-quarter.
  • 154 funds opened new Boston Scientific positions in Q4 2019 and 59 closed out, a net change of +95 holders.
  • The largest Boston Scientific buyer in Q4 2019 was Jennison Associates, an estimated $399M added.
  • The largest Boston Scientific seller in Q4 2019 was Wellington Management Group, an estimated $723M sold.

Based on aggregated 13F filings for Q4 2019.